This policy paper, initiated and funded by AstraZeneca and developed in collaboration with a multidisciplinary group of academics, clinicians, patient advocates, and cancer policy… Read More
Metastatic breast cancer patient Claudia shares her experience with ESR1 mutation testing and liquid biopsy: impact on treatment and access barriers. Read More
CPE Board Member Alina Comanescu’s colorectal cancer awareness video: importance of screening, early detection, and reducing cancer inequalities across Europe. Read More
CPE factsheet explains subcutaneous administration of cancer treatments: benefits, how it works, patient eligibility, and advantages over IV infusion. Read More
CPE factsheet explains combination therapies for cancer patients: how they work, why they’re used, side effects, and questions to ask your oncology team. Read More
CPE infographic explains the EU Joint Clinical Assessment (JCA) process with 7 patient involvement touchpoints under the new HTA Regulation. Read More
CPE’s guide explains personalised medicine for cancer patients: genomic testing, biomarkers, targeted therapies, and how to access precision oncology across Europe. Read More
This patient-facing factsheet explains biosimilar medicines in cancer care, describing them as highly similar alternatives to already-approved biological medicines that provide the same treatment… Read More
CPE’s survey on ESR1 mutations and liquid biopsy awareness among metastatic breast cancer patients across 5 EU countries informed the 2025 White Paper. Read More
PREVENT’s official brochure introduces the EU Horizon Europe project on childhood obesity prevention, with CPE as consortium partner. Read More